Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric lumen pH represents the concentration of hydrogen ions within the stomach cavity, typically maintained between 1.5 and 3.5 by the action of parietal cell H+/K+ ATPase pumps [1]. This highly acidic environment is fundamental for the digestive process, facilitating the denaturation of complex proteins and the conversion of pepsinogen into its active form, pepsin [1, 2]. Beyond digestion, the low pH serves as a critical innate immune barrier, neutralizing most ingested pathogens before they reach the lower gastrointestinal tract [2]. Pathological deviations in gastric acidity, or the failure of protective mucosal barriers against this acid, lead to conditions such as gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD) [3]. Therapeutic strategies targeting gastric lumen pH include the use of antacids for direct chemical neutralization and proton pump inhibitors (PPIs) or H2-receptor antagonists to suppress acid secretion [4]. While effective, chronic elevation of gastric pH can lead to complications such as impaired absorption of micronutrients (e.g., Vitamin B12, calcium) and an increased risk of enteric infections like Clostridioides difficile [4, 5]. Sources: [1] StatPearls: Physiology, Gastric Acid (https://www.ncbi.nlm.nih.gov/books/NBK537005/) [2] Britannica: Gastric Juice (https://www.britannica.com/science/gastric-juice) [3] Mayo Clinic: GERD (https://www.mayoclinic.org/diseases-conditions/gerd/symptoms-causes/syc-20361940) [4] StatPearls: Antacids (https://www.ncbi.nlm.nih.gov/books/NBK526049/) [5] FDA: PPI Safety Communications (https://www.fda.gov/drugs/postmarket-drug-safety-availability/fda-drug-safety-communication-clostridium-difficile-associated-diarrhea-can-be-associated-proton)
Direct chemical neutralization of hydrochloric acid by weak bases (antacids) or indirect modulation via inhibition of the gastric H+/K+ ATPase (proton pump inhibitors) and H2 receptors (H2-receptor antagonists) to increase pH levels.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric lumen pH (pH).